Literature DB >> 25663134

Is ursodeoxycholic acid crucial for ischemia/reperfusion-induced ovarian injury in rat ovary?

Ali Akdemir1, Cagdas Sahin, Oytun Erbas, Ahmet O Yeniel, Fatih Sendag.   

Abstract

PURPOSE: Ursodeoxycholic acid is frequently used in cholestatic liver diseases. Also, it protects hepatocytes against oxidative stress induced by hydrophobic bile acids. We investigated the anti-oxidative effect of ursodeoxycholic acid on ischemia/reperfusion injury after ovarian de-torsion in rats.
METHODS: We designed five study groups. Group 1 (n = 6): Sham-operated group; group 2 (n = 6): torsion group; group 3 (n = 6): torsion and ursodeoxycholic acid, group 4 (n = 7): torsion/de-torsion group; and group 5 (n = 7): torsion/de-torsion and ursodeoxycholic acid. After that, ovarian samples were obtained and examined histologically and tissue levels of malondialdehyde were measured.
RESULTS: Follicular degeneration, edema and inflammatory cells were significantly decreased in groups 3 and 5 in comparison with groups 2 and 4. Also, groups 4 and 5 were compared in terms of vascular congestion and hemorrhage and these were found to be significantly decreased in group 5. In addition, levels of malondialdehyde were significantly decreased in groups 3 and 5 in comparison with groups 2 and 4.
CONCLUSIONS: We concluded that ursodeoxycholic acid might be useful to protect the ovary against ischemia and reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25663134     DOI: 10.1007/s00404-015-3646-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Nigella Sativa Oil Protects the Rat Ovary from Oxidative Injury Due to Ischemia-Reperfusion.

Authors:  Melahat Atasever; Zeyneb Bakacak
Journal:  Med Sci Monit       Date:  2017-10-21

2.  The effect of a natural molecule in ovary ischemia reperfusion damage: does lycopene protect ovary?

Authors:  Demet Aydogan Kirmizi; Emre Baser; Aslı Okan; Mustafa Kara; Ethem Serdar Yalvac; Zuleyha Doganyigit
Journal:  Exp Anim       Date:  2020-09-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.